UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period
ended September 30, 2025
or
☐ TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period
from to
Commission File Number:
001-42731
1RT ACQUISITION CORP.
(Exact name of registrant
as specified in its charter)
Cayman Islands 33-1579459
(State or other jurisdiction of
incorporation or organization) (I.R.S. Employer
Identification No.)
205
West 28th Street
2nd Floor Suite C
New York, New York
10001
(Address of principal executive offices) (Zip Code)
(315) 810-1230
(Registrant’s telephone number, including
area code)
Not Applicable
(Former name, former address and former fiscal
year, if changed since last report)
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class Trading Symbol(s) Name
of each exchange on which registered
Units, each consisting of one Class A ordinary share and one-quarter of one redeemable warrant ONCHU The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share ONCH The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share ONCHW The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12
months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.
See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”
and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐
As of November 13, 2025, there were 17,250,000
Class A Ordinary Shares, par value $0.0001 per share and 4,312,500 Class B Ordinary Shares, par value $0.0001 per share, of the registrant
issued and outstanding.
1RT ACQUISITION CORP.
FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30,
2025
TABLE OF CONTENTS
Page
PART I – FINANCIAL INFORMATION
1
Item 1.
Interim Financial Statements.
1
Condensed Balance Sheets as of September 30, 2025 (Unaudited) and December 31, 2024
1
Condensed Statements of Operations for the Three and Nine Months Ended September 30, 2025 (Unaudited)
2
Condensed Statements of Changes in Shareholders’ (Deficit) Equity for the Three and Nine Months Ended September 30, 2025 (Unaudited)
3
Condensed Statement of Cash Flows for the Nine Months Ended September 30, 2025 (Unaudited)
4
Notes to Condensed Financial Statements (Unaudited)
5
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
18
Item 3.
Quantitative and Qualitative Disclosures About Market Risk.
20
Item 4.
Controls and Procedures.
20
PART II – OTHER INFORMATION
21
Item 1.
Legal Proceedings.
21
Item 1A.
Risk Factors.
21
Item 2.
Unregistered Sales of Equity
Securities and Use of Proceeds.
21
Item 3.
Defaults Upon Senior Securities.
21
Item 4.
Mine Safety Disclosures.
21
Item 5.
Other Information.
21
Item 6.
Exhibits.
22
SIGNATURES
23
i
PART I - FINANCIAL INFORMATION
Item 1. Interim Financial Statements.
1RT ACQUISITION CORP.
CONDENSED BALANCE SHEETS
September 30,
December 31,
2025
2024
(Unaudited)
Assets
Current assets
Cash
$ 741,229
$ —
Prepaid expenses
123,064
8,886
Total Current Assets
864,293
8,886
Long-Term prepaid insurance
65,860
—
Marketable securities held in Trust Account
174,183,318
—
Deferred offering costs
—
134,537
Total Assets
$ 175,113,471
$ 143,423
Liabilities, Class A Ordinary Shares subject to Possible Redemption, and Shareholders’ (Deficit) Equity
Current Liabilities
Accrued expenses
$ 204,278
$ —
Accrued offering costs
233,010
17,707
Promissory note - related party
—
120,648
Total Current Liabilities
437,288
138,355
Deferred underwriting fee payable
8,212,500
—
Total Liabilities
8,649,788
138,355
Commitments and Contingency (Note 6)
Class A ordinary shares subject to possible redemption, 17,250,000 shares at redemption value of $ 10.10 and $ 0.00 per share at September 30, 2025 and December 31, 2024, respectively
174,183,318
—
Shareholders’ (Deficit) Equity
Preference shares, $ 0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
—
—
Class A ordinary shares, $ 0.0001 par value; 200,000,000 shares authorized; none issued or outstanding (excluding 17,250,000 and 0 Class A ordinary shares subject to possible redemption) at September 30, 2025 and December 31, 2024, respectively
—
—
Class B ordinary shares, $ 0.0001 par value; 20,000,000 shares authorized; 4,312,500 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively
431
431
Additional paid-in capital
—
24,569
Accumulated deficit
( 7,720,066 )
( 19,932 )
Total Shareholders’ (Deficit) Equity
( 7,719,635 )
5,068
Total Liabilities and Shareholders’ (Deficit) Equity
$ 175,113,471
$ 143,423
The accompanying notes are an integral part of
the unaudited condensed financial statements.
1
1RT ACQUISITION CORP.
CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)
For the
Three Months
Ended
September 30,
For the
Nine Months
Ended
September 30,
2025
2025
General and administrative costs
$ 285,197
$ 357,464
Loss from operations
( 285,197 )
( 357,464 )
Other income:
Interest earned on marketable securities held in Trust Account
1,683,318
1,683,318
Total other income, net
1,683,318
1,683,318
Net income
$ 1,398,121
$ 1,325,854
Weighted average shares outstanding, Class A redeemable ordinary shares
16,870,879
5,644,301
Basic and diluted net income per share, Class A redeemable ordinary shares
$ 0.07
$ 0.14
Weighted average shares outstanding, Class B ordinary shares (1)
4,300,137
3,934,053
Basic net income per share, Class B ordinary shares
$ 0.07
$ 0.14
Weighted average shares outstanding, Class B ordinary shares (1)
4,312,500
3,938,189
Diluted net income per share, Class B ordinary shares
$ 0.07
$ 0.14
The accompanying notes are an integral part of
the unaudited condensed financial statements.
2
1RT ACQUISITION CORP.
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’
(DEFICIT) EQUITY
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER
30, 2025
(UNAUDITED)
Class A
Ordinary Shares
Class B
Ordinary Shares
Additional Paid-in
Accumulated
Total
Shareholders’
Equity
Shares
Amount
Shares
Amount
Capital
Deficit
(Deficit)
Balance — January 1, 2025
—
$ —
4,312,500
$ 431
$ 24,569
$ ( 19,932 )
$ 5,068
Net loss
—
—
—
—
—
( 31,000 )
( 31,000 )
Balance – March 31, 2025 (unaudited)
—
—
4,312,500
431
24,569
( 50,932 )
( 25,932 )
Net loss
—
—
—
—
—
( 41,267 )
( 41,267 )
Balance – June 30, 2025 (unaudited)
—
—
4,312,500
431
24,569
( 92,199 )
( 67,199 )
Sale of 2,250,000 Private Placement Warrants
—
—
—
—
4,500,000
—
4,500,000
Fair Value of Public Warrants at issuance
—
—
—
—
1,854,375
—
1,854,375
Allocated value of transaction costs to Class A shares
—
—
—
—
( 144,040 )
—
( 144,040 )
Accretion for Class A ordinary shares to redemption amount
—
—
—
—
( 6,234,904 )
( 9,025,988 )
( 15,260,892 )
Net income
—
—
—
—
—
1,398,121
1,398,121
Balance – September 30, 2025 (unaudited)
—
$ —
4,312,500
$ 431
$ —
$ ( 7,720,066 )
$ ( 7,719,635 )
The accompanying notes are an integral part of
the unaudited condensed financial statements.
3
1RT ACQUISITION CORP.
CONDENSED STATEMENT OF CASH FLOWS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2025
(UNAUDITED)
Cash Flows from Operating Activities:
Net income
$ 1,325,854
Adjustments to reconcile net income to net cash used in operating activities:
Payment of operation costs through promissory note
49,067
Interest earned on marketable securities held in Trust Account
( 1,683,318 )
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
( 123,064 )
Accrued expenses
204,278
Long-term prepaid insurance
( 65,860 )
Net cash used in operating activities
( 293,043 )
Cash Flows from Investing Activities:
Investment of cash in Trust Account
( 172,500,000 )
Net cash used in investing activities
( 172,500,000 )
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid
169,500,000
Proceeds from sale of Private Placements Warrants
4,500,000
Repayment of promissory note - related party
( 242,532 )
Payment of offering costs
( 223,196 )
Net cash provided by financing activities
173,534,272
Net Change in Cash
741,229
Cash – Beginning of period
—
Cash – End of period
$ 741,229
Non-Cash investing and financing activities:
Offering costs included in accrued offering costs
$ 233,010
Deferred offering costs paid through promissory note – related party
$ 72,817
Deferred offering costs applied to prepaid services contributed by Sponsor
$ 8,886
Deferred underwriting fee payable
$ 8,212,500
The accompanying notes are an integral part of
the unaudited condensed financial statements.
4
1RT ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2025
(Unaudited)
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
1RT Acquisition Corp. (the “Company”)
is a blank check company incorporated as a Cayman Islands exempted corporation on December 13, 2024 . The Company was incorporated
for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business
combination with one or more businesses (the “Business Combination”).
As of September 30, 2025, the Company has not
commenced any operations. All activity for the period from December 13, 2024 (inception) through September 30, 2025 relates to the
Company’s formation, the Initial Public Offering (as defined below), and subsequent to the Initial Public Offering, identifying
a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial
Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived
from the Initial Public Offering (as defined below). The Company has selected December 31 as its fiscal year end.
The registration statement for the Company’s
Initial Public Offering was declared effective on July 1, 2025. On July 3, 2025, the Company consummated the Initial Public Offering
of 17,250,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the
“Public Shares”), which includes the full exercise by the underwriters of their over-allotment option in the amount of 2,250,000
Units, at $ 10.00 per Unit, generating gross proceeds of $ 172,500,000 . Each Unit consists of one Class A ordinary share and one-quarter
of one redeemable warrant (“Public Warrant”). Each whole warrant will entitle the holder to purchase one Class A ordinary
share at a price of $ 11.50 per share, subject to adjustment. Each warrant will become exercisable 30 days after the completion of
the initial Business Combination and will expire five years after the completion of the initial Business Combination, or earlier
upon redemption or liquidation.
The Company’s Sponsor is 1RT Acquisition
Sponsor LLC (the “Sponsor”). Simultaneously with the closing of the Initial Public Offering, the Company consummated the
sale of an aggregate of 2,250,000 Private Placement Warrants (including if the underwriters’ over-allotment option is exercised
in full) (the “Private Placement Warrants”) in a private placement to the Sponsor and Cantor Fitzgerald & Co., the
representative of the underwriters of the Initial Public Offering, at a price of $ 2.00 per warrant, or $ 4,500,000 in the aggregate. Of
those 2,250,000 Private Placement Warrants, the Sponsor purchased 1,500,000 Private Placement Warrants and Cantor Fitzgerald &
Co. purchased 750,000 Private Placement Warrants. Each whole warrant entitles the holder to purchase one Class A ordinary share
at a price of $ 11.50 per share. The Company’s management has broad discretion with respect to the specific application of the net
proceeds of the Initial Public Offering and the Private Placement Warrants, although substantially all of the net proceeds are intended
to be generally applied toward consummating a Business Combination (less deferred underwriting commissions).
Transaction costs amounted to $ 11,867,239 , consisting
of $ 3,000,000 of cash underwriting fees, $ 8,212,500 of deferred underwriting fees, and $ 654,739 of other offering costs.
The Company’s Business Combination must
be with one or more target businesses that together have a fair market value equal to at least 80 % of the net balance in the Trust Account
(as defined below) (excluding the amount of deferred underwriting discounts held and taxes payable on the income earned on the Trust
Account) at the time of the signing an agreement to enter into a Business Combination. However, the Company will only complete a Business
Combination if the post-Business Combination company owns or acquires 50 % or more of the outstanding voting securities of the target
or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company
under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that
the Company will be able to successfully effect a Business Combination.
Following the closing of the Initial Public Offering,
on July 3, 2025, an amount of $ 172,500,000 ($ 10.00 per Unit) from the net proceeds of the sale of the Units and the Private Placement
Warrants was placed in the trust account (the “Trust Account”), with Continental Stock Transfer & Trust Company acting
as trustee. The funds may only be invested in U.S. government treasury obligations with a maturity of 185 days or less or in
money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct
U.S. government treasury obligations; the holding of these assets in this form is intended to be temporary and for the sole purpose
of facilitating the intended business combination. To mitigate the risk that the Company might be deemed to be an investment company
for purposes of the Investment Company Act, which risk increases the longer that the Company holds investments in the Trust Account,
the Company may, at any time (based on the management team’s ongoing assessment of all factors related to the Company’s potential
status under the Investment Company Act), instruct the trustee to liquidate the investments held in the Trust Account and instead to
hold the funds in the Trust Account in cash or in an interest bearing demand deposit account at a bank. Except with respect to interest
earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from the Initial
Public Offering and the sale of the Private Placement Warrants will not be released from the Trust Account until the earliest of (i) the
completion of the Company’s initial Business Combination, (ii) the redemption of the Company’s public shares if the
Company is unable to complete the initial Business Combination within 24 months from the closing of the Initial Public Offering
or by such earlier liquidation date as the Company’s board of directors may approve (the “Completion Window”), subject
to applicable law, or (iii) the redemption of the Company’s public shares properly submitted in connection with a shareholder
vote to amend the Company’s amended and restated memorandum and articles of association to (A) modify the substance or timing
of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100 % of the Company’s
public shares if the Company has not consummated an initial Business Combination within the Completion Window or (B) with respect
to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity. The proceeds deposited
in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the
claims of the Company’s public shareholders.
5
1RT ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2025
(Unaudited)
The Company will provide the Company’s
public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business
Combination either (i) in connection with a general meeting called to approve the initial Business Combination or (ii) without
a shareholder vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial
Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be
entitled to redeem their shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account
calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned
on the funds held in the Trust Account (less taxes payable), divided by the number of then outstanding public shares, subject to the
limitations. The amount in the Trust Account is initially anticipated to be $ 10.00 per public share.
The ordinary shares subject to redemption will
be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance
with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480,
“Distinguishing Liabilities from Equity.” In such case, if the Company seeks shareholder approval, a majority of the issued
and outstanding shares voted are voted in favor of the Business Combination.
The Company will have only the duration of the
Completion Window to complete the initial Business Combination. However, if the Company is unable to complete its initial Business Combination
within the Completion Window, the Company will as promptly as reasonably possible but not more than ten business days
thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust
Account, including interest earned on the funds held in the Trust Account (less taxes payable and up to $ 100,000 of interest to pay dissolution
expenses), divided by the number of then outstanding public shares, which redemption will constitute full and complete payment for the
public shares and completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation
or other distributions, if any), subject to the Company’s obligations under Cayman Islands law to provide for claims of creditors
and subject to the other requirements of applicable law.
The Sponsor, officers and directors have entered
into a letter agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to
their founder shares and public shares in connection with the completion of the initial Business Combination; (ii) waive their redemption
rights with respect to their founder shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s
amended and restated memorandum and articles of association; (iii) waive their rights to liquidating distributions from the Trust
Account with respect to their founder shares if the Company fails to complete the initial Business Combination within the Completion
Window, although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold
if the Company fails to complete the initial Business Combination within the Completion Window and to liquidating distributions from
assets outside the Trust Account; and (iv) vote any founder shares held by them and any public shares purchased during or after
the Initial Public Offering (including in open market and privately negotiated transactions, aside from shares they may purchase in compliance
with the requirements of Rule 14e-5 under the Exchange Act, which would not be voted in favor of approving the Business Combination)
in favor of the initial Business Combination. The Company’s sponsor, officers and directors did not receive any consideration for
such waivers.
The Company’s Sponsor has agreed that it
will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company,
or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar
agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $ 10.00 per
public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust
Account, if less than $ 10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability
will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies
held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity
of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933,
as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations,
nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company
believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would
be able to satisfy those obligations.
Liquidity, Capital Resources and Going
Concern
As of September 30, 2025, the Company had cash of $ 741,229 held outside of the Trust Account and working capital of $ 427,005 . The Company
will use such funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence
on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their
representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate
and complete a Business Combination.
In connection with the Company’s assessment
of going concern considerations in accordance with ASC 205-40, “Going Concern,” as of September 30, 2025, the Company may
need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third
parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time
or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs.
Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may
be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations,
suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new
financing will be available to it on commercially acceptable terms, if at all.
6
1RT ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2025
(Unaudited)
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES
Basis of Presentation
The accompanying unaudited condensed financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”)
for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the U.S. Securities
and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared
in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting.
Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial positions, results
of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments,
consisting of a normal recurring nature, which are necessary for a fair presentation of the financial positions, operating results and
cash flows for the periods presented.
The accompanying unaudited condensed financial
statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on
July 1, 2025, as well as the Company’s Current Report on Form 8-K, as filed with the SEC on July 10, 2025. The interim results
for the three and nine months ended September 30, 2025, are not necessarily indicative of the results to be expected for the year ending
December 31, 2025 or for any future periods.
Emerging Growth Company
The Company is an “emerging growth company,”
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012
(the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable
to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the
auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS
Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private
companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities
registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides
that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth
companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period,
which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company,
as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company
nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential
differences in accounting standards used.
Use of Estimates
The preparation of the unaudited condensed financial
statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial
statements and the reported amounts of expenses during the reporting periods.
Making estimates requires management to exercise
significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could
change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from
those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. As of September 30, 2025 and December 31, 2024,
the Company had $ 741,229 and $0 in cash and cash equivalents, respectively.
Marketable Securities Held in Trust Account
The Company’s portfolio of investments
is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity
of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable
fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government
securities, the investments are classified as trading securities. In contrast, when the investments held in Trust Account are comprised
of money market funds, these are recognized at fair value. Trading securities and investments in money market funds are presented on
the unaudited condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change
in fair value of these securities are included in income from investments held in the Trust Account in the accompanying unaudited condensed
statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
As of September 30, 2025, the assets held in the Trust Account were in money market funds.
7
1RT ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2025
(Unaudited)
Concentration of Credit Risk
Financial instruments that potentially subject
the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal
Deposit Insurance Corporation coverage limit of $ 250,000 . Any loss incurred or a lack of access to such funds could have a significant
adverse impact on the Company’s financial condition, results of operations, and cash flows.
Offering Costs
The Company complies with the requirements of
the ASC 340-10-S99 and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering.” Deferred offering costs
consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC 470-20, “Debt
with Conversion and Other Options,” addresses the allocation of proceeds from the issuance of convertible debt into its equity
and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A
ordinary shares and warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the
warrants and then to the Class A ordinary shares. Offering costs allocated to the Class A ordinary shares subject to possible
redemption will be charged to temporary equity and offering costs allocated to the Public and Private Placement Warrants will be charged
to shareholders’ deficit as Public Warrants (as defined below) and Private Placement Warrants, and, after management’s evaluation,
offering costs will be accounted for under equity treatment. Should the Initial Public Offering prove to be unsuccessful, these deferred
costs, as well as additional expenses to be incurred, will be charged to operations.
Fair Value of Financial Instruments
The fair value of the Company’s assets
and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,”
approximates the carrying amounts represented in the unaudited condensed balance sheets, primarily due to its short-term nature.
Class A Shares Subject to Possible Redemption
The Public Shares contain a redemption feature
which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder
vote or tender offer in connection with the Company’s initial Business Combination. In accordance with ASC 480-10-S99, the Company
classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control
of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable
shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering,
the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares
will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of September
30, 2025 and December 31, 2024, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary
equity, outside of the shareholders’ deficit section of the Company’s unaudited condensed balance sheets. As of September
30, 2025 and December 31, 2024, the Class A ordinary shares subject to possible redemption reflected in the unaudited condensed balance
sheets are reconciled in the following table:
Gross proceeds
$ 172,500,000
Less:
Proceeds allocated to public warrants
( 1,854,375 )
Public shares issuance costs
( 11,723,199 )
Plus:
Remeasurement of carrying value to redemption value
13,577,574
Class A Ordinary shares subject to possible redemption, July 3, 2025
172,500,000
Plus:
Remeasurement of carrying value to redemption value
1,683,318
Class A Ordinary shares subject to possible redemption, September 30, 2025
$ 174,183,318
8
1RT ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2025
(Unaudited)
Income Taxes
The Company accounts for income taxes under ASC
Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for
income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of
assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the
periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce
deferred tax assets to the amount expected to be realized.
ASC Topic 740 prescribes a recognition threshold
and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in
a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing
authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company
recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2025 and December
31, 2024, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware
of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company is considered to be an exempted Cayman
Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing
requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.
Derivative Financial Instruments
The Company evaluates its financial instruments
to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815,
“Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument
is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value
reported in the unaudited condensed statements of operations. The classification of derivative instruments, including whether such instruments
should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified
in the unaudited condensed balance sheets as current or non-current based on whether or not net cash settlement or conversion of the
instrument could be required within 12 months of the balance sheet date.
Warrant Instruments
The Company accounted for the Public and Private
Placement Warrants issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained
in FASB ASC Topic 815, “Derivatives and Hedging”. Accordingly, the Company evaluated and classified the warrant instruments
under equity treatment at their assigned values.
9
1RT ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2025
(Unaudited)
Net Income Per Ordinary Share
The Company complies with accounting and disclosure
requirements of FASB ASC Topic 260, “Earnings Per Share.” Income and losses are shared pro rata to the shares. Net income
per Ordinary Share is computed by dividing net income by the weighted average number of Ordinary Shares outstanding for the period. Accretion
associated with the redeemable Ordinary Shares is excluded from income per Ordinary Share as the redemption value approximates fair value.
The calculation of diluted income per Ordinary
Share does not consider the effect of the Warrants issued in connection with the (i) Initial Public Offering, (ii) the exercise of the
over-allotment option and (iii) Private Placement, since the average price of the Ordinary Shares for the nine months ended September
30, 2025 was less than the exercise price and therefore, the inclusion of such Warrants under the Treasury stock method would be anti-dilutive
and the exercise is contingent upon the occurrence of future events.
The following table reflects the calculation
of basic and diluted net income per Ordinary Share:
For the Three Months Ended
September 30, 2025
For the Nine Months Ended
September 30, 2025
Class A
Class B
Class A
Class B
Ordinary
Shares
Ordinary
Shares
Ordinary
Shares
Ordinary
Shares
Basic net income per Ordinary Share
Numerator:
Allocation of net income, as adjusted
$ 1,114,143
$ 283,978
$ 781,295
$ 544,559
Denominator:
Basic weighted average Ordinary Shares outstanding
16,870,879
4,300,137
5,644,301
3,934,053
Basic net income per Ordinary Share
$ 0.07
$ 0.07
$ 0.14
$ 0.14
For the Three Months Ended
September 30, 2025
For the Nine Months Ended
September 30, 2025
Class A
Class B
Class A
Class B
Ordinary
Shares
Ordinary
Shares
Ordinary
Shares
Ordinary
Shares
Diluted net income per Ordinary Share
Numerator:
Allocation of net income, as adjusted
$ 1,113,493
$ 284,628
$ 780,958
$ 544,896
Denominator:
Diluted weighted average Ordinary Shares outstanding
16,870,879
4,312,500
5,644,301
3,938,189
Diluted net income per Ordinary Share
$ 0.07
$ 0.07
$ 0.14
$ 0.14
Recent Accounting Standards
In November 2023, the FASB issued ASU 2023-07,
“Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” The amendments in this ASU require disclosures,
on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”),
as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that
a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment
profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all
annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to
provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective
for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early
adoption permitted. The Company adopted ASU 2023-07 on December 13, 2024, inception date.
Management does not believe that any other recently
issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial
statement.
10
1RT ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2025
(Unaudited)
NOTE 3. INITIAL PUBLIC OFFERING
Pursuant to the Initial Public Offering on July
3, 2025, the Company sold 17,250,000 Units, which includes the full exercise by underwriters of their over-allotment option in
the amount of 2,250,000 Units at a purchase price of $ 10.00 per Unit. Each Unit that the Company is offering has a price of $ 10.00 and
consists of one Class A ordinary share and one-quarter of one redeemable warrant (“Public Warrant”). Each whole warrant
will entitle the holder to purchase one Class A ordinary share at a price of $ 11.50 per share, subject to adjustment. Each warrant
will become exercisable 30 days after the completion of the initial Business Combination and will expire five years after the
completion of the initial Business Combination, or earlier upon redemption or liquidation.
Public Warrants — As of
September 30, 2025, there are 4,312,500 Public Warrants outstanding. At December 31, 2024, there are no Public Warrants outstanding.
Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $ 11.50 per share, subject to adjustment
as discussed herein. The warrants cannot be exercised until 30 days after the completion of the initial Business Combination, and
will expire at 5:00 p.m., New York City time, five years after the completion of the initial Business Combination or earlier
upon redemption or liquidation.
The Company will not be obligated to deliver
any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless
a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective
and a prospectus relating thereto is current. No warrant will be exercisable and the Company will not be obligated to issue a Class A
ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered,
qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the
event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such
warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will the Company
be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the
purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the Class A ordinary
share underlying such unit.
Under the terms of the warrant agreement, the
Company has agreed that, as soon as practicable, but in no event later than 20 business days after the closing of its Business
Combination, it will use commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement
for the Initial Public Offering or a new registration statement covering the registration under the Securities Act of the Class A
ordinary shares issuable upon exercise of the warrants and thereafter will use its commercially reasonable efforts to cause the same
to become effective within 60 business days following the Company’s initial business combination and to maintain a current
prospectus relating to the Class A ordinary shares issuable upon exercise of the warrants until the expiration of the warrants in
accordance with the provisions of the warrant agreement. If a registration statement covering the Class A ordinary shares issuable
upon exercise of the warrants is not effective by the sixtieth ( 60 th ) business day after the closing of the initial Business
Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company
will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with
Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares
are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a
“covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders
of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of
the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration
statement, and in the event the Company does not so elect, the Company will use its commercially reasonable efforts to register or qualify
the shares under applicable blue sky laws to the extent an exemption is not available.
If the holders exercise their Public Warrants
on a cashless basis, they would pay the warrant exercise price by surrendering the warrants for that number of Class A ordinary
shares equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants,
multiplied by the excess of the “fair market value” of the Class A ordinary shares over the exercise price of the warrants
by (y) the fair market value. The “fair market value” is the average reported closing price of the Class A ordinary
shares for the 10 trading days ending on the third trading day prior to the date on which the notice of exercise
is received by the warrant agent or on which the notice of redemption is sent to the holders of warrants, as applicable.
Redemption of Warrants When the Price per
Class A Ordinary Share Equals or Exceeds $ 18.00 : The Company may redeem the outstanding warrants:
● in whole and not in part;
● at a price of $ 0.01 per warrant;
● upon a minimum of 30 days’ prior written notice of redemption (the “ 30 -day redemption period”); and
● if, and only if, the closing price of the Class A ordinary shares equals or exceeds $ 18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within a 30 -trading day period commencing at least 30 days after completion of the Company’s initial business combination and ending three business days before the Company sends the notice of redemption to the warrant holders.
11
1RT ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2025
(Unaudited)
Additionally, if the number of outstanding Class A
ordinary shares is increased by a share capitalization payable in Class A ordinary shares, or by a subdivision of ordinary
shares or other similar event, then, on the effective date of such share capitalization, subdivision or similar event, the number
of Class A ordinary shares issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding
ordinary shares. A rights offering made to all or substantially all holders of ordinary shares entitling holders to purchase Class A
ordinary shares at a price less than the fair market value will be deemed a share capitalization of a number of Class A ordinary
shares equal to the product of (i) the number of Class A ordinary shares actually sold in such rights offering (or issuable
under any other equity securities sold in such rights offering that are convertible into or exercisable for Class A ordinary shares)
and (ii) the quotient of (x) the price per Class A ordinary share paid in such rights offering and (y) the fair market
value. For these purposes (i) if the rights offering is for securities convertible into or exercisable for Class A ordinary
shares, in determining the price payable for Class A ordinary shares, there will be taken into account any consideration received
for such rights, as well as any additional amount payable upon exercise or conversion and (ii) fair market value means the volume
weighted average price of Class A ordinary shares as reported during the ten ( 10 ) trading day period ending on the trading day
prior to the first date on which the Class A ordinary shares trade on the applicable exchange or in the applicable market, regular
way, without the right to receive such rights.
NOTE 4. PRIVATE PLACEMENT
Simultaneously with the closing of the Initial
Public Offering, the Sponsor and Cantor Fitzgerald & Co. purchased an aggregate of 2,250,000 Private Placement Warrants at a
price of $ 2.00 per warrant, or $ 4,500,000 in the aggregate, in a private placement. Of those 2,250,000 Private Placement Warrants, the
Sponsor purchased 1,500,000 Private Placement Warrants and Cantor Fitzgerald & Co. purchased 750,000 Private Placement Warrants.
Each whole warrant entitles the registered holder to purchase one Class A ordinary share at a price of $ 11.50 per share, subject
to adjustment.
The Private Placement Warrants will be identical
to the Public Warrants sold in the Initial Public Offering except that, so long as they are held by the Sponsor, Cantor Fitzgerald &
Co., or their permitted transferees, the Private Placement Warrants (i) may not (including the Class A ordinary shares issuable
upon exercise of these Private Placement Warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders
until 30 days after the completion of the initial Business Combination, (ii) will be entitled to registration rights and (iii) with
respect to Private Placement Warrants held by Cantor Fitzgerald & Co. and/or its designees, will not be exercisable more than
five years from the commencement of sales in the Initial Public Offering in accordance with Financial Industry Regulatory Authority
(“FINRA”) Rule 5110(g)(8).
The Sponsor, officers and directors have entered
into a letter agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to
their founder shares and public shares in connection with the completion of the initial Business Combination; (ii) waive their redemption
rights with respect to their founder shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s
amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation
to allow redemption in connection with the initial Business Combination or to redeem 100 % of the public shares if the Company has not
consummated an initial Business Combination within the Completion Window or (B) with respect to any other material provisions relating
to shareholders’ rights or pre-initial Business Combination activity; (iii) waive their rights to liquidating distributions
from the Trust Account with respect to their founder shares if the Company fails to complete the initial Business Combination within
the Completion Window, although they will be entitled to liquidating distributions from the Trust Account with respect to any public
shares they hold if the Company fails to complete the initial Business Combination within the Completion Window and to liquidating distributions
from assets outside the Trust Account; and (iv) vote any founder shares held by them and any public shares purchased during or after
the Initial Public Offering (including in open market and privately negotiated transactions, aside from shares they may purchase in compliance
with the requirements of Rule 14e-5 under the Exchange Act, which would not be voted in favor of approving the Business Combination)
in favor of the initial Business Combination. The Company’s sponsor, officers and directors did not receive any consideration for
such waivers.
NOTE 5. RELATED PARTY TRANSACTIONS
Founder Shares
On December 31, 2024, the Sponsor made a
capital contribution of $ 25,000 , or approximately $ 0.006 per share, to cover certain of the Company’s expenses, for which the Company
issued 4,312,500 founders shares to the Sponsor. Up to 562,500 of the founder shares may be surrendered by the Sponsor for no consideration
depending on the extent to which the underwriters’ over-allotment option is exercised. On July 3, 2025, the underwriters exercised
their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 562,500 founder shares are no
longer subject to forfeiture.
On July 1, 2025, the Sponsor granted membership
interests equivalent to an aggregate of 75,000 founder shares to directors of the Company in exchange for the payment of $ 144.93 by each
director and for their services through the Company’s initial Business Combination. The founder shares, represented by such membership
interests, will remain with the Sponsor if the holder of such membership interests are no longer serving the Company prior to the initial
Business Combination. The membership interest assignment of the founder shares to the holders of such interests are in the scope of FASB
ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated
with equity-classified awards is measured at fair value upon the assignment date. The total fair value of the 75,000 founder shares represented
by such membership interests assigned to the holders of such interests on July 1, 2025 was $ 193,500 or $ 2.58 per share. The membership
interests were assigned subject to a performance condition (i.e., providing services through Business Combination). Stock-based compensation
would be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) in
an amount equal to the number of membership interests that ultimately vest times the assignment date fair value per share (unless subsequently
modified) less the amount initially received for the assignment of the membership interests. As of July 3, 2025, the Company determined
that the initial Business Combination is not considered probable and therefore no compensation expense has been recognized.
12
1RT ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2025
(Unaudited)
The Company’s initial shareholders have
agreed not to transfer, assign or sell any of their founder shares and any Class A ordinary shares issued upon conversion thereof
until the earlier to occur of (i) one year after the completion of the initial Business Combination or (ii) the date on which
the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that
results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities
or other property. Any permitted transferees will be subject to the same restrictions and other agreements of the Company’s initial
shareholders with respect to any founder shares (the “Lock-up”). Notwithstanding the foregoing, if (1) the closing price
of the Class A ordinary shares equals or exceeds $ 12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations,
recapitalizations and the like) for any 20 trading days within any 30 -trading day period commencing at least 150 days
after the initial Business Combination or (2) if the Company consummates a transaction after the initial Business Combination which
results in the Company’s shareholders having the right to exchange their shares for cash, securities or other property, the founder
shares will be released from the Lock-up.
Promissory Note — Related
Party
The Sponsor has agreed to loan the Company an
aggregate of up to $ 300,000 to be used for a portion of the expenses of the Initial Public Offering. The loan is non-interest bearing,
unsecured and due at the earlier of September 1, 2025, as amended, or the closing of the Initial Public Offering. The loan was repaid
out of the offering allocated to the payment of offering expenses. As of September 30, 2025, the Company repaid the total outstanding
balance of the loan amounting to $ 242,532 . The borrowings under the Note are no longer available.
Due from Sponsor
On July 3, 2025, the Company paid $ 24,350 in
excess of the outstanding borrowings under the Note. On July 9, 2025, the Sponsor returned $ 24,350 to the Company. As of September 30,
2025 and December 31, 2024, there was $0 and $ 62,118 , respectively, outstanding which is currently due on demand.
Administrative Services Agreement
The Company entered into an agreement with the
affiliate of the Sponsor, commencing on July 3, 2025, the effective date of the Initial Public Offering, to pay an aggregate of $ 12,500
per month for office space, utilities, and secretarial and administrative support. For the three months ended September 30, 2025, the
Company incurred $ 37,500 in fees for these services, of which such amount is included in accounts payable and accrued expenses in the
accompanying unaudited condensed balance sheets.
Working Capital Loans
In order to finance transaction costs in connection
with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may,
but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes
a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the
Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from
the Trust Account would be used to repay the Working Capital Loans. Up to $ 1,500,000 of such Working Capital Loans may be convertible
into private placement warrants of the post Business Combination entity at a price of $ 2.00 per warrant at the option of the lender.
The warrants would be identical to the Private Placement Warrants. As of September 30, 2025 and December 31, 2024, no such Working Capital
Loans were outstanding.
13
1RT ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2025
(Unaudited)
NOTE 6. COMMITMENTS AND CONTINGENCY
Risks and Uncertainties
The United States and global markets are
experiencing volatility and disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine conflict and
the Israel-Hamas conflict. In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty Organization (“NATO”)
deployed additional military forces to eastern Europe, and the United States, the United Kingdom, the European Union and other countries
have announced various sanctions and restrictive actions against Russia, Belarus and related individuals and entities, including the
removal of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication payment system. Certain
countries, including the United States, have also provided and may continue to provide military aid or other assistance to Ukraine
and to Israel, increasing geopolitical tensions among a number of nations. The invasion of Ukraine by Russia and the Israel-Hamas conflict
and the resulting measures that have been taken, and could be taken in the future, by NATO, the United States, the United Kingdom,
the European Union, Israel and its neighboring states and other countries have created global security concerns that could have a lasting
impact on regional and global economies. Although the length and impact of the ongoing conflicts are highly unpredictable, they could
lead to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply chain
interruptions and increased cyberattacks against U.S. companies. Additionally, any resulting sanctions could adversely affect the
global economy and financial markets and lead to instability and lack of liquidity in capital markets.
Any of the above mentioned factors, or any other
negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion of Ukraine,
the Israel-Hamas conflict and subsequent sanctions or related actions, could adversely affect the Company’s search for an initial
business combination and any target business with which the Company may ultimately consummate an initial business combination.
Registration Rights
The holders of the founder shares, Private Placement
Warrants and the Class A ordinary shares underlying such Private Placement Warrants and Private Placement Warrants and warrants
that may be issued upon conversion of the Working Capital Loans will have registration rights to require the Company to register a sale
of any of the Company’s securities held by them and any other securities of the Company acquired by them prior to the consummation
of the initial Business Combination pursuant to a registration rights agreement to be signed prior to or on the effective date of the
Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that
the Company registers such securities. In addition, the holders have certain piggyback registration rights with respect to registration
statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection
with the filing of any such registration statements.
Underwriters’ Agreement
The underwriters had a 45 -day option from the
date of the Initial Public Offering to purchase up to an additional 2,250,000 units to cover over-allotments, if any. On July 3,
2025, the underwriters elected to fully exercise their over-allotment option to purchase an additional 2,250,000 Units at a price of
$ 10.00 per Unit.
14
1RT ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2025
(Unaudited)
The underwriters were entitled to a cash underwriting
discount of $ 3,000,000 ( 2.0 % of the gross proceeds of the units offered in the Initial Public Offering, excluding the proceeds from units
sold pursuant to the underwriters’ over-allotment option). Additionally, the underwriters were entitled to a deferred underwriting
discount of 4.50 % of the gross proceeds of the Initial Public Offering held in the Trust Account other than those sold pursuant to the
underwriters’ over-allotment option and 6.50 % of the gross proceeds sold pursuant to the underwriters’ over-allotment option,
$ 8,212,500 in the aggregate as the underwriters’ exercised their over-allotment option in full upon the completion of the Company’s
initial Business Combination subject to the terms of the underwriting agreement.
NOTE 7. STOCKHOLDERS’ (DEFICIT) EQUITY
Preference Shares — The
Company is authorized to issue a total of 1,000,000 preference shares at par value of $ 0.0001 each. At September 30, 2025 and December
31, 2024, there were no preference shares issued or outstanding.
Class A Ordinary Shares — The
Company is authorized to issue a total of 200,000,000 Class A ordinary shares at par value of $ 0.0001 each. At September 30, 2025,
there were no shares of Class A ordinary shares issued or outstanding, excluding 17,250,000 shares subject to possible redemption
presented in temporary equity. At December 31, 2024, there were no Class A ordinary shares issued or outstanding.
Class B Ordinary Shares — The
Company is authorized to issue a total of 20,000,000 Class B ordinary shares at par value of $ 0.0001 each. On December 31,
2024, the Company issued 4,312,500 Class B ordinary shares to the Sponsor for $ 25,000 , or approximately $ 0.006 per share. The founder
shares include an aggregate of up to 562,500 shares subject to forfeiture if the over-allotment option is not exercised by the underwriters
in full. On July 3, 2025, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public
Offering. As such, the 562,500 founder shares are no longer subject to forfeiture. As of September 30, 2025 and December 31, 2024, there
were 4,312,500 Class B ordinary shares issued and outstanding.
The founder shares will automatically convert
into Class A ordinary shares concurrently with or immediately following the consummation of the initial Business Combination or
earlier at the option of the holder on a one-for-one basis, subject to adjustment for share subdivisions, share capitalizations, reorganizations,
recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary
shares, or any other equity-linked securities, are issued or deemed issued in excess of the amounts sold in this offering and related
to or in connection with the closing of the initial business combination, the ratio at which Class B ordinary shares convert into
Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree
to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable
upon conversion of all Class B ordinary shares will equal, in the aggregate, 20 % of the sum of (i) the total number of all
Class A ordinary shares outstanding upon the completion of the Initial Public Offering (including any Class A ordinary shares
issued pursuant to the underwriters’ over-allotment option and excluding the Class A ordinary shares underlying the private
placement warrants issued to the Sponsor), plus (ii) all Class A ordinary shares and equity-linked securities issued or deemed
issued, in connection with the closing of the initial Business Combination (excluding any shares or equity-linked securities issued,
or to be issued, to any seller in the initial business combination and any private placement-equivalent warrants issued to the Sponsor
or any of its affiliates or to the Company’s officers or directors upon conversion of working capital loans) minus (iii) any
redemptions of Class A ordinary shares by public shareholders in connection with an initial business combination; provided that
such conversion of founder shares will never occur on a less than one-for-one basis.
Holders of record of the Company’s Class A
ordinary shares and Class B ordinary shares are entitled to one vote for each share held on all matters to be voted on by shareholders.
Unless specified in the amended and restated memorandum and articles of association or as required by the Companies Act or stock exchange
rules, an ordinary resolution under Cayman Islands law and the amended and restated memorandum and articles of association, which requires
the affirmative vote of a majority of the shareholders who, being entitled to do so, vote in person or, where proxies are allowed, by
proxy at a general meeting of the company is generally required to approve any matter voted on by the Company’s shareholders. Approval
of certain actions requires a special resolution under Cayman Islands law, which (except as specified below) requires the affirmative
vote of at least two-thirds of the shareholders who, being entitled to do so, vote in person or, where proxies are allowed, by proxy
at a general meeting, and pursuant to the Company’s amended and restated memorandum and articles of association, such actions include
amending the amended and restated memorandum and articles of association and approving a statutory merger or consolidation with another
company. There is no cumulative voting with respect to the appointment of directors, meaning, following the Company’s initial business
combination, the holders of more than 50 % of the ordinary shares voted for the appointment of directors can elect all of the directors.
Prior to the consummation of the initial Business Combination, only holders of the Class B ordinary shares will (i) have the
right to vote on the appointment and removal of directors and (ii) be entitled to vote on continuing the Company in a jurisdiction
outside the Cayman Islands (including any special resolution required to amend the constitutional documents or to adopt new constitutional
documents, in each case, as a result of approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands). Holders
of the Class A ordinary shares will not be entitled to vote on these matters during such time. These provisions of the amended and
restated memorandum and articles of association may only be amended if approved by a special resolution passed by the affirmative vote
of at least 90 % (or, where such amendment is proposed in respect of the consummation of the initial Business Combination, two-thirds)
of the shareholders who, being entitled to do so, vote in person or, where proxies are allowed, by proxy at a general meeting of the
Company.
15
1RT ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2025
(Unaudited)
NOTE 8. FAIR VALUE MEASUREMENTS
The fair value of the Company’s financial
assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale
of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the
measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of
observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions
about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and
liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
Level 1:
Quoted prices
in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions
for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
Level 2:
Observable inputs other
than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted
prices for identical assets or liabilities in markets that are not active.
Level 3:
Unobservable inputs based
on assessment of the assumptions that market participants would use in pricing the asset or liability.
The fair value of the Public Warrants issued
in the Initial Public Offering is $ 1,854,375 , or $ 0.43 per Public Warrant. The Public Warrants issued in the Initial Public Offering
have been classified within shareholders’ deficit and will not require remeasurement after issuance. The following table presents
the quantitative information regarding market assumptions used in the valuation of the Public Warrants issued in the Initial Public Offering:
July 3,
2025
Traded unit price $ 10.34
Expected term to De-SPAC 2 years
Warrant term 7 years
Probability of De-SPAC and market adjustment 30.0 %
Risk-free rate (continuous) 4.02 %
At September 30, 2025, assets held in the Trust
Account were comprised of $ 174,183,318 in money market funds which are invested primarily in U.S. Treasury Securities.
The following table presents information about
the Company’s assets that are measured at fair value on a recurring basis at September 30, 2025 and indicates the fair value hierarchy
of the valuation inputs the Company utilized to determine such fair value:
Description
Level
September 30,
2025
Assets:
Marketable securities held in Trust Account – U.S. Treasury Securities Money Market Fund
1
$
174,183,318
16
1RT ACQUISITION CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2025
(Unaudited)
NOTE 9. SEGMENT INFORMATION
ASC Topic 280, “Segment Reporting,”
establishes standards for companies to report in their financial statement information about operating segments, products, services,
geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information
is available that is regularly evaluated by the Company’s CODM, or group, in deciding how to allocate resources and assess performance.
The Company’s CODM has been identified
as the Chief Financial Officer , who reviews the assets, operating results, and financial metrics for the Company as a whole to make decisions
about allocating resources. Accordingly, management has determined that the Company only has one reportable segment.
The CODM assesses performance for the single
segment and decides how to allocate resources. The measure of segment assets is reported on the unaudited condensed balance sheets as
total assets. When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews
several key metrics, which include the following:
September 30,
2025
December 31,
2024
Cash
$ 741,229
$ —
Marketable Securities held in Trust Account
$ 174,183,318
$ —
For the
Three Months
Ended
September 30,
For the
Nine Months
Ended
September 30,
2025
2025
General and administrative costs
$ 285,197
$ 357,464
Interest earned on marketable securities held in Trust Account
$ 1,683,318
$ 1,683,318
General and administrative costs are reviewed
and monitored by the CODM to manage and forecast cash to ensure that enough capital is available to complete an Initial Public Offering
and eventually a Business Combination within the business combination period. The CODM also reviews general and administrative costs
to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget.
General and administrative costs, as reported
on the unaudited condensed statements of operations, are the significant segment expenses provided to the CODM on a regular basis.
All other segment items included in net income
or loss are reported on the unaudited condensed statements of operations and described within their respective disclosures.
NOTE 10. SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions
that occurred after the unaudited condensed balance sheets date through September 30, 2025, the date that the financial statement was
issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure
in the financial statement.
17
Item 2. Management’s Discussion and
Analysis of Financial Condition and Results of Operations
Cautionary Note Regarding Forward-Looking
Statements
This Quarterly Report includes “forward-looking
statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”),
and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are not historical facts
and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements,
other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s
Discussion and Analysis of Financial Condition and Results of Operations” regarding the completion of the Business Combination,
the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking
statements. Words such as “anticipate,” “believe,” “can,” “continue,” “could,”
“estimate,” “expect,” “intend,” “may,” “will,” “plan,” “project,”
“seek,” “should,” “target,” “will,” “would,” and similar expressions or variations
intended to identify forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect
management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance
or results to differ materially from the events, performance and results discussed in the forward-looking statements, including that
the conditions of the Business Combination are not satisfied. For information identifying important factors that could cause actual results
to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s
final prospectus for its Initial Public Offering filed with the U.S. Securities and Exchange Commission (the “SEC”). The
Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly
required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements
whether as a result of new information, future events or otherwise.
The following discussion and analysis of our
financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the
notes thereto included in this Report under Item 1. “Financial Statements”.
Overview
We are a blank check company incorporated in
the Cayman Islands on December 13, 2024, formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition,
share purchase, reorganization or other similar Business Combination with one or more businesses (“Business Combination”).
We intend to effectuate our Business Combination using cash derived from the proceeds of the Initial Public Offering and the sale of
the Private Placement Warrants, our shares, debt or a combination of cash, shares and debt.
We expect to continue to incur significant costs
in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.
Results of Operations
We have neither engaged in any operations nor
generated any revenues to date. Our only activities from December 13, 2024 (inception) through September 30, 2025 were organizational
activities and those necessary to prepare for the Initial Public Offering, described below. We do not expect to generate any operating
revenues until after the completion of our Business Combination. Subsequent to the Initial Public Offering, we generate non-operating
income in the form of interest income on marketable securities held in the Trust Account. We incur expenses as a result of being a public
company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended September 30, 2025,
we had a net income of $1,398,121, which consists of interest income on marketable securities held in the Trust Account of $1,683,318,
offset by operating costs of $285,197.
For the nine months ended September 30, 2025,
we had a net income of $1,325,854, which consists of interest income on marketable securities held in the Trust Account of $1,683,318,
offset by operating costs of $357,464.
Factors That May Adversely Affect our Results of Operations
Our results of operations and our ability to
complete an initial Business Combination may be adversely affected by various factors that could cause economic uncertainty and volatility
in the financial markets, many of which are beyond our control. Our results of operations and our ability to consummate an initial Business
Combination could be impacted by, among other things, downturns in the financial markets or in economic conditions, increases in oil
prices, inflation, fluctuations in interest rates, increases in tariffs, supply chain disruptions, declines in consumer confidence and
spending, public health considerations, and geopolitical instability, such as the military conflicts in Ukraine and the Middle East.
We cannot at this time predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which
they may negatively impact our business and our ability to complete an initial Business Combination.
18
Liquidity, Capital Resources and Going Concern
On July 3, 2025, we consummated the Initial Public
Offering of 17,250,000 Units, which includes the full exercise by the underwriters of their over-allotment option in the amount of 2,250,000
Units, at $10.00 per Unit, generating gross proceeds of $172,500,000. Simultaneously with the closing of the Initial Public Offering,
we consummated the sale of an aggregate of 2,250,000 Private Placement Warrants, at a price of $2.00 per warrant, or $4,500,000 in the
aggregate. Of those 2,250,000 Private Placement Warrants, the Sponsor purchased 1,500,000 Private Placement Warrants and Cantor Fitzgerald &
Co. purchased 750,000 Private Placement Warrants.
Following the Initial Public Offering, the full
exercise of the over-allotment option, and the sale of the Units, a total of $172,500,000 was placed in the Trust Account. We incurred
$11,867,239 in Initial Public Offering related costs, consisting of $3,000,000 of cash underwriting fees, $8,212,500 of deferred underwriting
fees, and $654,739 of other offering costs.
For the nine months ended September 30, 2025,
cash used in operating activities was $293,043. Net income of $1,325,854 was affected by payment of operation costs through promissory
note of $49,067 and interest earned on marketable securities held in the Trust Account of $1,683,318. Changes in operating assets and
liabilities used $15,354 of cash for operating activities.
As of September 30, 2025, we had marketable securities
held in the Trust Account of $174,183,318 (including approximately $1,683,318 of interest income) consisting of U.S. Treasury Bills with
a maturity of 185 days or less. We may withdraw interest from the Trust Account to pay taxes, if any. We intend to use substantially
all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes
payable), to complete our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration
to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the
operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
As of September 30, 2025, we had cash of $741,229.
We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due
diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses
or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure,
negotiate and complete a Business Combination.
In order to fund working capital deficiencies
or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their
affiliates may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such
loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the
Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000
of such Working Capital Loans may be convertible into private placement warrants of the post Business Combination entity at a price of
$2.00 per warrant at the option of the lender.
In connection with the Company’s assessment
of going concern considerations in accordance with ASC 205-40, “Going Concern,” as of September 30, 2025, the Company may
need to raise additional capital through loans or additional investments from its Sponsor, stockholders, officers, directors, or third
parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time
or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs.
Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may
be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations,
suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new
financing will be available to it on commercially acceptable terms, if at all.
Off-Balance Sheet Arrangements
We have no obligations, assets or liabilities,
which would be considered off-balance sheet arrangements as of September 30, 2025. We do not participate in transactions that create
relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have
been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing
arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial
assets.
Contractual Obligations
We do not have any long-term debt, capital lease
obligations, operating lease obligations or long-term liabilities, other than an agreement with the affiliate of the Sponsor, to pay
an aggregate of $12,500 per month for office space, utilities, and secretarial and administrative support. We began incurring these fees
on July 3, 2025 and will continue to incur these fees monthly until the earlier of the completion of the Business Combination and our
liquidation.
The underwriters had a 45-day option from the
date of the Initial Public Offering to purchase up to an additional 2,250,000 units to cover over-allotments, if any. On July 3,
2025, the underwriters elected to fully exercise their over-allotment option to purchase an additional 2,250,000 Units at a price of
$10.00 per Unit.
19
Critical Accounting Estimates
The preparation of unaudited condensed financial
statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets
and liabilities at the date of the financial statements, and income and expenses during the periods reported. Making estimates requires
management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation
or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate,
could change in the near term due to one or more future confirming events. Accordingly, the actual results could materially differ from
those estimates. As of September 30, 2025, we did not have any critical accounting estimates to be disclosed.
Class A Ordinary Shares Subject to Possible
Redemption
We account for our ordinary shares subject to
possible conversion in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing
Liabilities from Equity.” Ordinary shares subject to mandatory redemption are classified as a liability instrument and measured
at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within
the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified
as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. Our ordinary shares feature certain
redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly,
ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’
equity section of our unaudited condensed balance sheets.
Net Income Per Ordinary Share
The Company complies with accounting and disclosure
requirements of FASB ASC Topic 260, “Earnings Per Share.” Income and losses are shared pro rata to the shares. Net income
per Ordinary Share is computed by dividing net income by the weighted average number of Ordinary Shares outstanding for the period. Accretion
associated with the redeemable Ordinary Shares is excluded from income per Ordinary Share as the redemption value approximates fair value.
Recent Accounting Standards
Management does not believe that any recently
issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our unaudited condensed financial
statements.
Item 3. Quantitative and Qualitative Disclosures
About Market Risk
Not required for smaller reporting companies.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are controls
and other procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange
Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure
controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed
in our reports filed or submitted under the Exchange Act is accumulated and communicated to Management, including our Chief Executive
Officer and Chief Financial Officer (together, the “Certifying Officers”), or persons performing similar functions, as appropriate,
to allow timely decisions regarding required disclosure.
Under the supervision and with the participation
of our Management, including our Certifying Officers, we carried out an evaluation of the effectiveness of the design and operation of
our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on the foregoing, our
Certifying Officers concluded that our disclosure controls and procedures were effective as of the end of the quarterly period ended
September 30, 2025.
Changes in Internal Control over Financial
Reporting
There was no change in our internal control over
financial reporting that occurred during the fiscal quarter of 2025 covered by this Quarterly Report on Form 10-Q that has materially
affected, or is reasonably likely to materially affect, our internal control over financial reporting.
20
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
None
Item 1A. Risk Factors
Factors that could cause our actual results to
differ materially from those in this report include the risk factors described in our final prospectus for its Initial Public Offering
filed with the SEC. As of the date of this Report, there have been no material changes to the risk factors disclosed in our final prospectus
for its Initial Public Offering filed with the SEC.
Item 2. Unregistered Sales of Equity Securities
and Use of Proceeds.
On July 3, 2025, we consummated the Initial Public
Offering of 17,250,000 Units, which includes the full exercise by the underwriters of their over-allotment option in the amount of 2,250,000
Units, at $10.00 per Unit, generating gross proceeds of $172,500,000. Cantor Fitzgerald & Co., acted as sole book-running manager
and Roberts & Ryan acted as co-manager, of the Initial Public Offering. The securities in the offering were registered under the
Securities Act on registration statement on Form S-1 (No. 333-287941). The Securities and Exchange Commission declared the registration
statements effective on July 1, 2025.
Simultaneously with the closing of the Initial Public Offering, we
consummated the sale of an aggregate of 2,250,000 Private Placement Warrants (the “Private Placement Warrants”) in a private
placement to the Sponsor and Cantor Fitzgerald & Co., at a price of $2.00 per warrant, or $4,500,000 in the aggregate. Of those 2,250,000
Private Placement Warrants, the Sponsor purchased 1,500,000 Private Placement Warrants and Cantor Fitzgerald & Co. purchased
750,000 Private Placement Warrants. Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50
per share. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial
Public Offering and the Private Placement Warrants, although substantially all of the net proceeds are intended to be generally applied
toward consummating a Business Combination (less deferred underwriting commissions). The issuance was made pursuant to the exemption from
registration contained in Section 4(a)(2) of the Securities Act.
Of the gross proceeds received from the Initial
Public Offering, the exercise of the over-allotment option and the Private Placement Warrants, an aggregate of $172,500,000 was placed
in the Trust Account.
We paid a total of $11,867,239, consisting of
$3,000,000 of cash underwriting fees, $8,212,500 of deferred underwriting fees, and $654,739 of other offering costs and expenses related
to the Initial Public Offering.
For a description of the use of the proceeds
generated in our Initial Public Offering, see Part I, Item 2 of this Form 10-Q.
Item 3. Defaults Upon Senior Securities
None
Item 4. Mine Safety Disclosures
None
Item 5. Other Information
None of our officers or directors, as defined
in Rule 16a-1(f), adopted , modified , or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading
arrangement,” as defined in Item 408 of Regulation S-K, during the three months ended September 30, 2025.
21
Item 6. Exhibits
The following exhibits are filed as part of,
or incorporated by reference into, this Quarterly Report on Form 10-Q.
No.
Description
of Exhibit
3.1
Amended and Restated Memorandum and Articles of Association of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on July 3, 2025).
4.1
Warrant Agreement, dated July 1, 2025, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed with the SEC on July 3, 2025).
10.1
Investment Management Trust Agreement, July 1, 2025, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on July 3, 2025).
10.2
Registration Rights Agreement, dated July 1, 2025, by and among the Company and certain security holders (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K, filed with the SEC on July 3, 2025).
10.3
Sponsor Private Placement Warrants Purchase Agreement, dated July 1, 2025, by and between the Company and the Sponsor (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K, filed with the SEC on July 3, 2025).
10.4
Cantor Private Placement Warrants Purchase Agreement, dated July 1, 2025, by and between the Company and the Sponsor (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K, filed with the SEC on July 3, 2025).
10.5
Letter Agreement, dated July 1, 2025, by and among the Company, its officers, directors, and the Sponsor (incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K, filed with the SEC on July 3, 2025).
10.6
Form of Indemnity Agreement (incorporated by reference to Exhibit 10.6 to the Company’s Registration Statement on Form S-1, filed with the SEC on June 11, 2025).
10.7
Form of Director Award Agreement (incorporated by reference to Exhibit 10.11 to the Company’s Registration Statement on Form S-1, filed with the SEC on June 11, 2025).
31.1*
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*
Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*
XBRL Instance Document
101.SCH*
XBRL Taxonomy Extension
Schema Document
101.CAL*
XBRL Taxonomy Extension
Calculation Linkbase Document
101.DEF*
XBRL Taxonomy Extension
Definition Linkbase Document
101.LAB*
XBRL Taxonomy Extension
Labels Linkbase Document
101.PRE*
XBRL Taxonomy Extension
Presentation Linkbase Document
104
Cover Page Interactive
Data File (formatted as Inline XBRL and contained in Exhibit 101).
*
Filed herewith.
22
SIGNATURES
In accordance with the requirements
of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
1RT
ACQUISITION CORP.
Date:
November 13, 2025
By:
/s/
Dan Tapiero
Name:
Dan
Tapiero
Title:
Chief
Executive Officer
(principal
executive officer)
Date:
November 13, 2025
By:
/s/
Joe Majocha
Name:
Joe
Majocha
Title:
Chief
Financial Officer
(principal
financial and accounting officer)
23
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.